RxDoctor Payments Data

Erica Schuster, MD

Family Medicine · South Point, OHNPI 1477014322

Payments from drug & device makers

$914in general payments, 2019–2025

Across 58 payments — averaging $15.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$398
  • Pfizer$124
  • Boehringer Ingelheim$82
  • Lilly USA, LLC$59
  • Amgen$53
  • Mylan Specialty L.p.$49
  • plus $149 from 7 others

What the payments were for

  • Food & beverage$914100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$914 in reported general payments places this provider in the 60th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$29,652
Medicare patients
146
Services billed
724

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide93$96,150
RinvoqUpadacitinib12$78,193
JardianceEmpagliflozin54$69,700
Trelegy ElliptaFluticasone/Umeclidin/Vilanter53$40,875
JanuviaSitagliptin Phosphate30$34,662
FarxigaDapagliflozin Propanediol39$33,930
EliquisApixaban19$30,591
VraylarCariprazine Hcl16$29,717
XareltoRivaroxaban23$25,089
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog14$24,158
TrulicityDulaglutide23$22,445
MounjaroTirzepatide16$17,759
TradjentaLinagliptin12$16,627
LinzessLinaclotide16$16,281
Spiriva RespimatTiotropium Bromide22$13,347

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieRinvoq, Vraylar, Linzess, Savella$398$133,67556 claims
Boehringer IngelheimJardiance, Tradjenta, Spiriva Respimat$82$99,67588 claims
Novo NordiskOzempic$15$96,15093 claims
GSKTrelegy Ellipta, Breo Ellipta$14$50,42975 claims
Lilly USA, LLCTrulicity, Mounjaro$59$40,20439 claims
AstraZenecaFarxiga, Symbicort$45$38,87359 claims
PfizerEliquis$124$30,59119 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in South Point

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →